238 related articles for article (PubMed ID: 22247228)
41. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
Gugliucci A; Lunceford N; Kinugasa E; Ogata H; Schulze J; Kimura S
Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
[TBL] [Abstract][Full Text] [Related]
42. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
43. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.
Péquériaux NC; Fijnheer R; Gemen EF; Barendrecht AD; Dekker FW; Krediet RT; Beutler JJ; Boeschoten EW; Roest M
Nephrol Dial Transplant; 2012 Jun; 27(6):2452-7. PubMed ID: 22189209
[TBL] [Abstract][Full Text] [Related]
44. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
45. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
[TBL] [Abstract][Full Text] [Related]
46. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
47. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
[TBL] [Abstract][Full Text] [Related]
48. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
49. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
50. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
51. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
[TBL] [Abstract][Full Text] [Related]
52. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Bayrak T; Dursun P; Bayrak A; Gültekin M; Kolusarı A; Cakır E; Ozyurt M; Zeyneloğlu HB
Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
[TBL] [Abstract][Full Text] [Related]
53. Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension.
Baráth A; Németh I; Karg E; Endreffy E; Bereczki C; Gellén B; Haszon I; Túri S
Kidney Blood Press Res; 2006; 29(3):144-51. PubMed ID: 16912512
[TBL] [Abstract][Full Text] [Related]
54. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
[TBL] [Abstract][Full Text] [Related]
55. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T
Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651
[TBL] [Abstract][Full Text] [Related]
56. PON1 lactonase activity and its association with cardiovascular disease.
Murillo-González FE; Ponce-Ruiz N; Rojas-García AE; Rothenberg SJ; Bernal-Hernández YY; Cerda-Flores RM; Mackness M; Barrón-Vivanco BS; González-Arias CA; Ponce-Gallegos J; Medina-Díaz IM
Clin Chim Acta; 2020 Jan; 500():47-53. PubMed ID: 31626760
[TBL] [Abstract][Full Text] [Related]
57. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
58. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
Perla-Kaján J; Jakubowski H
FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
[TBL] [Abstract][Full Text] [Related]
59. Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status.
Yildiz G; Aydin H; Mağden K; Yilmaz A; Hür E; Candan F
Minerva Med; 2014 Feb; 105(1):79-87. PubMed ID: 24572453
[TBL] [Abstract][Full Text] [Related]
60. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
